Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szczepanski, T.
Right arrow Articles by van Dongen, J. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szczepanski, T.
Right arrow Articles by van Dongen, J. J. M.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 96 No. 3 (August 1), 2000: pp. 1087-1093

Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgHminus subgroup of multiple myeloma

Tomasz Szczepanski, Mars B. van 't Veer, Ingrid L. M. Wolvers-Tettero, Anton W. Langerak, and Jacques J. M. van Dongen

From the Department of Immunology and Department of Hematology, Erasmus University Rotterdam/University Hospital Rotterdam, Rotterdam, The Netherlands; Department of Paediatric Haematology and Chemotherapy, Silesian Medical Academy, Zabrze, Poland.

This study involved 12 patients with multiple myeloma (MM), in whom malignant plasma cells did not contain immunoglobulin heavy chain (IgH) protein chains. Southern blot analysis revealed monoallelic JH gene rearrangements in 10 patients, biallelic rearrangement in 1 patient, and biallelic deletion of the JH and Cµ regions in 1 patient. Heteroduplex polymerase chain reaction analysis enabled the identification and sequencing of 9 clonal JH gene rearrangements. Only 4 of the joinings were complete VH-(D)-JH rearrangements, including 3 in-frame rearrangements with evidence of somatic hypermutation. Five rearrangements concerned incomplete DH-JH joinings, mainly associated with deletion of the other allele. Curiously, in at least 1 of these 5 cases the second allele seemed to be in germline configuration, whereas the in-frame Vkappa -Jkappa gene rearrangements contained somatic mutations. The configuration of the IGH genes was further investigated by use of CH probes. In 5 patients the rearrangements in the JH and CH regions were not concordant, probably caused by illegitimate IGH class switch recombination (chromosomal translocations to 14q32.3). These data indicate that in many IgH- MM patients illegitimate IGH class switch rearrangement or illegitimate deletion of the functional VH-(DH)-JH allele are responsible for IgH negativity. For example, the exclusive presence of DH-JH rearrangements in combination with mutated IGK genes can only be explained in terms of normal B-cell development, if the second (functional) IGH allele is deleted, which was probably the case in most patients. Therefore, defects at the DNA level are responsible for the lack of IgH protein production in most IgH- MM patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. Gonzalez, M. van der Burg, R. Garcia-Sanz, J. A. Fenton, A. W. Langerak, M. Gonzalez, J. J. M. van Dongen, J. F. San Miguel, and G. J. Morgan
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
Blood, November 1, 2007; 110(9): 3112 - 3121.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
M. A. Dawson, S. Patil, and A. Spencer
Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains
Haematologica, January 1, 2007; 92(1): 143 - 144.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. V. Rajkumar, R. A. Kyle, T. M. Therneau, L. J. Melton III, A. R. Bradwell, R. J. Clark, D. R. Larson, M. F. Plevak, A. Dispenzieri, and J. A. Katzmann
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
Blood, August 1, 2005; 106(3): 812 - 817.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Magrangeas, M.-L. Cormier, G. Descamps, N. Gouy, L. Lode, M.-P. Mellerin, J.-L. Harousseau, R. Bataille, S. Minvielle, and H. Avet-Loiseau
Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level
Blood, May 15, 2004; 103(10): 3869 - 3875.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Magrangeas, V. Nasser, H. Avet-Loiseau, B. Loriod, O. Decaux, S. Granjeaud, F. Bertucci, D. Birnbaum, C. Nguyen, J.-L. Harousseau, et al.
Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
Blood, June 15, 2003; 101(12): 4998 - 5006.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020